Co-Authors
This is a "connection" page, showing publications co-authored by Alexander Supady and Dawid Staudacher.
Connection Strength
3.582
-
Outcome Prediction in Patients with Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation-A Retrospective International Multicenter Study. Membranes (Basel). 2021 Feb 27; 11(3).
Score: 0.932
-
Mobile ECMO retrieval of patients during the COVID-19 pandemic. Artif Organs. 2021 Oct; 45(10):1168-1172.
Score: 0.239
-
Conservative management of COVID-19 associated hypoxaemia. ERJ Open Res. 2021 Apr; 7(2).
Score: 0.238
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021 07; 9(7):755-762.
Score: 0.236
-
Survival after extracorporeal membrane oxygenation in severe COVID-19 ARDS: results from an international multicenter registry. Crit Care. 2021 03 01; 25(1):90.
Score: 0.233
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial. BMJ Open. 2021 01 17; 11(1):e043345.
Score: 0.231
-
Hospital networks and patient transport capacity during the COVID-19 pandemic when intensive care resources become scarce. Crit Care. 2021 01 12; 25(1):28.
Score: 0.231
-
Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study. Artif Organs. 2021 Jun; 45(6):593-601.
Score: 0.230
-
Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients. J Thromb Thrombolysis. 2021 Jul; 52(1):76-84.
Score: 0.228
-
Cytokine adsorption in a patient with severe coronavirus disease 2019 related acute respiratory distress syndrome requiring extracorporeal membrane oxygenation therapy: A case report. Artif Organs. 2021 02; 45(2):191-194.
Score: 0.226
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation. Crit Care. 2020 07 14; 24(1):435.
Score: 0.223
-
First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report. ASAIO J. 2020 06; 66(6):607-609.
Score: 0.221
-
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID-19. Pharmacol Res Perspect. 2021 04; 9(2):e00743.
Score: 0.059
-
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
Score: 0.055